Science Explorer Back to mapMap
Discussion
Company · Hartford · United States

Genomas (United States)

Research works
20
▼ 75% vs 2018-21
Citations
448
22.6 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
29%
world 40%
International
26%
world 18%

Not ranked overall: Genomas (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Genomas (United States) work in?

In all years, 54% of research at Genomas (United States) is in Life Sciences, 40% in Health Sciences. Its largest fields are Medicine (39%), Biochemistry, Genetics and Molecular Biology (36%), Pharmacology, Toxicology and Pharmaceutics (13%). It does 2.3× the world's share of Life Sciences.

Life Sciences: 11 fractional works · 53.9% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 35.9% of its workGenetics: 3 fractional works · 16.5% of its workMolecular Biology: 2 fractional works · 8.5% of its workCancer Research: 1 fractional works · 5.9% of its workBiochemistry: 1 fractional works · 3.2% of its workClinical Biochemistry: 0 fractional works · 0.9% of its workCell Biology: 0 fractional works · 0.6% of its workBiotechnology: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 12.7% of its workPharmacology: 3 fractional works · 12.7% of its workNeuroscience: 1 fractional works · 4.1% of its workCognitive Neuroscience: 0 fractional works · 2.1% of its workEndocrine and Autonomic Systems: 0 fractional works · 1.0% of its workBiological Psychiatry: 0 fractional works · 0.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 1.0% of its workImmunology: 0 fractional works · 0.6% of its workVirology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workPlant Science: 0 fractional works · 0.3% of its workHealth Sciences: 8 fractional works · 40.2% of its workMedicine: 8 fractional works · 39.3% of its workSurgery: 1 fractional works · 6.3% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 5.0% of its workPharmacology: 1 fractional works · 4.3% of its workPhysiology: 1 fractional works · 4.2% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 3.7% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 2.7% of its workPsychiatry and Mental health: 0 fractional works · 2.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 2.2% of its workEpidemiology: 0 fractional works · 2.1% of its workAnesthesiology and Pain Medicine: 0 fractional works · 1.8% of its workRheumatology: 0 fractional works · 1.0% of its workInfectious Diseases: 0 fractional works · 0.8% of its workOncology: 0 fractional works · 0.7% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.6% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.9% of its workPharmacy: 0 fractional works · 0.9% of its workPhysical Sciences: 1 fractional works · 3.9% of its workComputer Science: 0 fractional works · 2.2% of its workComputational Theory and Mathematics: 0 fractional works · 1.4% of its workSignal Processing: 0 fractional works · 0.9% of its workMathematics: 0 fractional works · 1.3% of its workStatistics and Probability: 0 fractional works · 1.3% of its workMaterials Science: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 2.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.5% of its workEconomics and Econometrics: 0 fractional works · 1.5% of its workPsychology: 0 fractional works · 0.6% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.6% of its workALL ITS WORKGenomas (UnitedStates)20fractional works, all years
Life Sciences54%Physical Sciences4%Health Sciences40%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology735.9%
    2. Pharmacology, Toxicology and Pharmaceutics312.7%
    3. Neuroscience14.1%
    4. Immunology and Microbiology01.0%
    5. Agricultural and Biological Sciences00.3%
    1. Medicine839.3%
    2. Health Professions00.9%
    1. Computer Science02.2%
    2. Mathematics01.3%
    3. Materials Science00.4%
    1. Economics, Econometrics and Finance01.5%
    2. Psychology00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Genomas (United States)?

Ranked on the quality score, Andreas Windemuth and Mohan Kocherla lead among researchers whose main affiliation is Genomas (United States).

  1. 1 Andreas Windemuth United States · #1,467,287 worldwide 4.5k citations · 91 works
  2. 2 Mohan Kocherla United States · #4,449,109 worldwide 1.1k citations · 38 works
All ranked researchers at Genomas (United States)

What are the most cited papers from Genomas (United States)?

The most cited paper from Genomas (United States) is "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 , OPRM1 , and COMT Genotypes and Select Opioid Therapy" (Kristine R. Crews et al., 2021), with 427 citations. Next come "Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA" (280) and "Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia" (261).

Most cited papers
#PaperReleasedCitations
1 Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 , OPRM1 , and COMT Genotypes and Select Opioid Therapy Kristine R. Crews et al. · Clinical Pharmacology & Therapeutics Open access 2 Jan 2021 427
2 Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA Jingyu Liu, Godfrey D. Pearlson, Andreas Windemuth et al. · Human Brain Mapping Open access 10 Dec 2007 280
3 Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia Shashwath A. Meda, Gualberto Ruaño, Andreas Windemuth et al. · Proceedings of the National Academy of Sciences Open access 28 Apr 2014 261
4 PharmVar GeneFocus: CYP2D6 Charity Nofziger, Amy Jane Turner, Katrin Sangkuhl et al. · Clinical Pharmacology & Therapeutics Open access 23 Sep 2019 254
5 A clinical study of the association of antipsychotics with hyperlipidemia José de León, Margaret T. Susce, Maria S. Johnson et al. · Schizophrenia Research 9 Mar 2007 77
All 75 most cited papers, with filters and sorting

Which research topics does Genomas (United States) publish most on?

By volume in 2022-now: Statistical Methods and Inference, vaccines and immunoinformatics approaches, Viral Infections and Outbreaks Research and Machine Learning in Bioinformatics.

  1. 1 Statistical Methods and Inference Statistics and Probability 0 works
  2. 2 vaccines and immunoinformatics approaches Molecular Biology 0 works
  3. 3 Viral Infections and Outbreaks Research Infectious Diseases 0 works
  4. 4 Machine Learning in Bioinformatics Molecular Biology 0 works
  5. 5 Genomics and Rare Diseases Genetics 0 works
  6. 6 Spondyloarthritis Studies and Treatments Rheumatology 0 works
  7. 7 Gene expression and cancer classification Molecular Biology 0 works
  8. 8 Amyotrophic Lateral Sclerosis Research Neurology 0 works
  9. 9 Bioinformatics and Genomic Networks Molecular Biology 0 works
  10. 10 Advanced Biosensing Techniques and Applications Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.2%not open70.8%

World: 40% of research is openly available.

with international co-authors26.2%domestic only73.8%

World: 18% is written across borders.

How has Genomas (United States)'s research output changed?

Output in 2022-2025 was 75% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Genomas (United States) as a percentage of every work published that year, 0.00000097% in 2021.

still counting0.000050%0.00010%0.00015%Genomas (United States)0.0000099% in 202520102020

Fractional works of Genomas (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Hartford

All research institutions in Hartford

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Genomas (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.